• レポートコード:TMR2008036 • 出版社/出版日:Transparency Market Research / 2020年5月 • レポート形態:英文、PDF、161ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥857,660 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,301,660 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは流動性止血剤の世界市場について調査・分析し、序文、仮定・調査手法、エグゼクティブサマリー、市場概要、市場見通し、材質別(豚ゼラチン、牛ゼラチン)分析、用途別(一般手術、心臓手術、血管手術、神経・脊椎手術、整形外科手術)分析、エンドユーザー別(病院、クリニック、緊急手術センター)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、以下の構成でご提供いたします。 ・序文 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場見通し ・流動性止血剤の世界市場:材質別(豚ゼラチン、牛ゼラチン) ・流動性止血剤の世界市場:用途別(一般手術、心臓手術、血管手術、神経・脊椎手術、整形外科手術) ・流動性止血剤の世界市場:エンドユーザー別(病院、クリニック、緊急手術センター) ・流動性止血剤の世界市場:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ) ・競争状況 |
Flowable Hemostats Market – Scope of the Report
TMR’s report on the global flowable hemostats market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the global flowable hemostats market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global flowable hemostats market during the forecast period.
The report has been prepared after extensive primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global flowable hemostats market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global flowable hemostats market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global flowable hemostats market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global flowable hemostats market.
The report delves into the competition landscape of the global flowable hemostats market. Key players operating in the global flowable hemostats market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global flowable hemostats market that have been profiled in this report.
Key Questions Answered in Flowable Hemostats Market Report
What is the scope of growth of companies in the global flowable hemostats market?
What will be the Y-o-Y growth of the global flowable hemostats market between 2019 and 2027?
What is the influence of changing trends in technologies on the global flowable hemostats market?
Will North America continue to be the most profitable market for flowable hemostats providers?
Which factors will hamper the growth of the global flowable hemostats market during the forecast period?
Which are the leading companies in the global flowable hemostats market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global flowable hemostats market and arrive at conclusions on the growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global flowable hemostats market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who have contributed to the production of TMR’s study on the flowable hemostats market as primary sources.
These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from flowable hemostats market leaders. Access to extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global flowable hemostats market with accuracy. The study also uses the top-down approach to assess the revenue numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global flowable hemostats market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Flowable Hemostats Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Key Market Trends
4.4. Global Flowable Hemostats Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Flowable Hemostats Pricing Analysis
5.2. Brand Analysis: Floseal vs. Surgiflo
5.3. Pipeline Analysis: Advanced Hemostasis Products Market
5.4. Regulatory Scenario
5.5. Reimbursement Assessment Overview
6. Global Flowable Hemostats Market Analysis and Forecast, by Material
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Material, 2017–2027
6.3.1. Porcine Gelatin
6.3.2. Bovine Gelatin
6.4. Market Attractiveness Analysis, by Material
7. Global Flowable Hemostats Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2027
7.3.1. General Surgery
7.3.2. Cardiac Surgery
7.3.3. Vascular Surgery
7.3.4. Neuro & Spine Surgery
7.3.5. Orthopedic Surgery
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Flowable Hemostats Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Ambulatory Surgery Centers
8.4. Market Attractiveness Analysis, by End-user
9. Global Flowable Hemostats Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis By Region
10. North America Flowable Hemostats Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast, by Material, 2017–2027
10.2.1. Porcine Gelatin
10.2.2. Bovine Gelatin
10.3. Market Value Forecast, by Application, 2017–2027
10.3.1. General Surgery
10.3.2. Cardiac Surgery
10.3.3. Vascular Surgery
10.3.4. Neuro & Spine Surgery
10.3.5. Orthopedic Surgery
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgery Centers
10.5. Market Value Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Material
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Flowable Hemostats Market Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast, by Material, 2017–2027
11.2.1. Porcine Gelatin
11.2.2. Bovine Gelatin
11.3. Market Value Forecast, by Application, 2017–2027
11.3.1. General Surgery
11.3.2. Cardiac Surgery
11.3.3. Vascular Surgery
11.3.4. Neuro & Spine Surgery
11.3.5. Orthopedic Surgery
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgery Centers
11.5. Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Material
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Flowable Hemostats Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast, by Material, 2017–2027
12.2.1. Porcine Gelatin
12.2.2. Bovine Gelatin
12.3. Market Value Forecast, by Application, 2017–2027
12.3.1. General Surgery
12.3.2. Cardiac Surgery
12.3.3. Vascular Surgery
12.3.4. Neuro & Spine Surgery
12.3.5. Orthopedic Surgery
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgery Centers
12.5. Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Material
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Flowable Hemostats Market Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast, by Material, 2017–2027
13.2.1. Porcine Gelatin
13.2.2. Bovine Gelatin
13.3. Market Value Forecast, by Application, 2017–2027
13.3.1. General Surgery
13.3.2. Cardiac Surgery
13.3.3. Vascular Surgery
13.3.4. Neuro & Spine Surgery
13.3.5. Orthopedic Surgery
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgery Centers
13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Material
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Flowable Hemostats Market Analysis and Forecast
14.1. Introduction
14.2. Market Value Forecast, by Material, 2017–2027
14.2.1. Porcine Gelatin
14.2.2. Bovine Gelatin
14.3. Market Value Forecast, by Application, 2017–2027
14.3.1. General Surgery
14.3.2. Cardiac Surgery
14.3.3. Vascular Surgery
14.3.4. Neuro & Spine Surgery
14.3.5. Orthopedic Surgery
14.3.6. Others
14.4. Market Value Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Ambulatory Surgery Centers
14.5. Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Material
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Share Analysis, by Company, 2018
15.2. Company Profiles
15.2.1. Johnson & Johnson
15.2.1.1. Company Overview
15.2.1.2. Company Financials
15.2.1.3. Growth Strategies
15.2.1.4. SWOT Analysis
15.2.2. Baxter International, Inc.
15.2.2.1. Company Overview
15.2.2.2. Company Financials
15.2.2.3. Growth Strategies
15.2.2.4. SWOT Analysis
15.2.3. Teleflex Incorporated
15.2.3.1. Company Overview
15.2.3.2. Company Financials
15.2.3.3. Growth Strategies
15.2.3.4. SWOT Analysis
List of TablesTable 01: Brand Analysis: Floseal vs. Surgiflo
Table 02: Global Flowable Hemostats Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 03: Global Flowable Hemostats Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 04: Global Flowable Hemostats Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 05: Global Flowable Hemostats Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Flowable Hemostats Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 07: North America Flowable Hemostats Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 08: North America Flowable Hemostats Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 09: North America Flowable Hemostats Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 10: Europe Flowable Hemostats Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 11: Europe Flowable Hemostats Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 12: Europe Flowable Hemostats Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 13: Europe Flowable Hemostats Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 14: Asia Pacific Flowable Hemostats Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 15: Asia Pacific Flowable Hemostats Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 16: Asia Pacific Flowable Hemostats Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 17: Asia Pacific Flowable Hemostats Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Latin America Flowable Hemostats Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 19: Latin America Flowable Hemostats Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 20: Latin America Flowable Hemostats Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 21: Latin America Flowable Hemostats Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 22: Middle East & Africa Flowable Hemostats Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 23: Middle East & Africa Flowable Hemostats Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 24: Middle East & Africa Flowable Hemostats Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 25: Middle East & Africa (MEA) Flowable Hemostats Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027